Lifeway Foods, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lifeway Foods, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $103.35M | Apr 19, 2019 |
| FY2018 | Dec 31, 2017 | $118.89M | Apr 19, 2019 |
| FY2015 | Dec 31, 2015 | $137.24M | Apr 10, 2017 |
| FY2015 | Dec 31, 2014 | $130.22M | Apr 10, 2017 |
| FY2015 | Dec 31, 2013 | $108.97M | Apr 10, 2017 |
| FY2014 | Dec 31, 2012 | $89.75M | Aug 14, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.50M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $186.82M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $160.12M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $141.57M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $119.07M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $102.03M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | $93.66M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $103.35M | Apr 14, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.86M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $9.03M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $11.37M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $924.0K | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $3.31M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $3.23M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | $453.0K | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($3.09M) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($346.0K) | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | $3.48M | Mar 30, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.17M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $13.85M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $17.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.35M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $5.88M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $4.92M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | ($1.93M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($3.11M) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($526.0K) | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | $6.09M | Mar 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.61M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $90.55M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $81.65M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $69.00M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $70.87M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $61.25M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | $56.99M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $56.81M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $64.52M | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | $65.21M | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.79M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $18.64M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $21.22M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $21.43M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $21.74M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $14.40M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | $13.74M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $14.40M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $17.93M | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | $16.85M | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.82M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $71.91M | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | $60.44M | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | $47.57M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $49.13M | Mar 20, 2024 |
| FY2022 | Dec 31, 2020 | $46.85M | Mar 27, 2023 |
| FY2020 | Dec 31, 2019 | $43.25M | Mar 25, 2021 |
| FY2020 | Dec 31, 2018 | $42.41M | Mar 25, 2021 |
| FY2019 | Dec 31, 2017 | $46.59M | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | $48.36M | Apr 19, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 30, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $16.73M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $13.20M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $4.44M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $9.23M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $7.93M | Jul 21, 2022 |
| FY2020 | Dec 31, 2019 | $3.84M | Mar 25, 2021 |
| FY2020 | Dec 31, 2018 | $3.00M | Mar 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.98M | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | $8.81M | Apr 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.75M | Mar 20, 2024 |
| FY2022 | Dec 31, 2022 | $3.75M | Mar 27, 2023 |
| FY2021 | Dec 31, 2021 | $4.50M | Jul 21, 2022 |
| FY2018 | Dec 31, 2017 | $6.28M | Apr 19, 2019 |
| FY2017 | Dec 31, 2016 | $7.12M | Mar 30, 2018 |
| FY2015 | Dec 31, 2015 | $7.96M | Apr 10, 2017 |
| FY2015 | Dec 31, 2014 | $9.00M | Apr 10, 2017 |
| FY2014 | Dec 31, 2013 | $9.87M | Aug 14, 2015 |
| FY2013 | Dec 31, 2012 | $5.50M | Apr 2, 2014 |
| FY2012 | Dec 31, 2011 | $7.08M | Apr 1, 2013 |